Naproxen Hcs (Naproxen Sodium)

Naproxen, the active ingredient in Naproxen Hcs, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is employed to relieve pain, reduce inflammation, and lower fever in adult patients with musculoskeletal and inflammatory conditions.

GNH USA supplies Naproxen Hcs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Customers benefit from reliable logistics, competitive pricing, and responsive technical support.

Naproxen Hcs, an NSAID, acts on inflammatory pathways to provide symptomatic relief in several musculoskeletal and gynecologic conditions.

- Pain: alleviates mild to moderate acute or chronic pain. - Inflammation: reduces swelling and redness associated with inflammatory processes. - Osteoarthritis: improves joint pain and stiffness in osteoarthritis patients. - Rheumatoid arthritis: helps control pain and inflammation in rheumatoid arthritis. - Dysmenorrhea: eases menstrual cramps and associated discomfort.

Naproxen Hcs may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate tension‑type headache. - Dizziness: transient feeling of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration: potentially life‑threatening hemorrhage. - Cardiovascular events: increased risk of myocardial infarction or stroke. - Renal impairment: acute kidney injury or worsening chronic kidney disease. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing Naproxen Hcs, clinicians should evaluate patient‑specific risk factors and follow recommended safety measures.

- Assess gastrointestinal risk: consider history of ulcers, bleeding, or concurrent NSAID use. - Evaluate cardiovascular profile: avoid in patients with recent myocardial infarction or uncontrolled hypertension. - Monitor renal function: use caution in those with impaired kidney function or dehydration. - Use lowest effective dose: limit duration to the shortest period necessary for symptom control. - Avoid in known hypersensitivity: contraindicated in patients allergic to naproxen or other NSAIDs. - Store at room temperature: keep in the original container, protect from moisture and heat.

Naproxen Hcs can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened chance of ulceration and bleeding. - Lithium: naproxen may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: potential for decreased effectiveness and renal impairment. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk.